ArticleScientific reports2025

Genome-wide CRISPR/Cas9 screening identifies PTGR2 as a potential therapeutic target for sunitinib resistance in clear cell renal cell carcinoma.

Wei Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.